The thought occurred to me the other day:
We know that there seem to be several types of tinnitus. There are different responses among tinnitus sufferers to the same treatment: some improve, some get worse, and some are even cured.
Once the Bionics Institute puts its machinery on the market and it becomes available in audiology departments or ENT clinics, imagine this scenario: Patient A goes in for an examination, and the printout from the machine reads:
- Tinnitus: detected
- Volume: 10 decibels at the 6,000 kHz frequency
- Source of Tinnitus: 5 cm northwest of the dorsal cochlear nucleus
With this data, ENTs and audiologists would be able to build a knowledge base on which therapy or pharmaceutical option might best alleviate that specific type of tinnitus. I didn't say "cure"—that would be too optimistic, but it's not beyond imagination.
For instance, Patient B's brain scan might show significant activity in the area connected to the nerve in the jaw, indicating a potential case of TMJ. The quest for a single, one-size-fits-all pharmaceutical cure for tinnitus (such as Lidocaine) could then become more of an academic pursuit, perhaps reserved for further study and future research.
The introduction of the Bionics Institute device could bring tinnitus relief to the forefront, allowing for customized, personalized treatments for each patient.
A step forward? I suppose I'll believe it when I see it, as the saying goes.